posted on 2020-11-26, 05:30authored byShejuan An, Jeannie M. Camarillo, Tina Yi-Ting Huang, Daphne Li, Juliette A. Morris, Madeline A. Zoltek, Jin Qi, Mandana Behbahani, Madhuri Kambhampati, Neil L. Kelleher, Javad Nazarian, Paul M. Thomas, Amanda M. Saratsis
Additional file 2: S2. Targeted mass spectrometry for histone tail analysis. Overview of study design and analysis of histone tail post-translational modification states in pediatric glioma specimens. Tumor tissue specimens were obtained post-mortem or during the course of treatment. Patient-derived tumor cell lines were established from tissue specimens. Extracted histones were analyzed using targeted mass spectrometry of the histone H3 and H4 N-terminal tail, with quantitation of histone post-translational modifications (me1, me2, me3, ac) and unmodified peptide on lysine (K) residues.
Funding
National Institute of Neurological Disorders and Stroke National Resource for Translational and Developmental Proteomics National Cancer Institute